Besides, the restoration of the functionality of the p53 tumor-suppressing effect, which in turn renders the tumor cells more vulnerable to the DNA damage caused by anti-cancer drugs and regulate various apoptotic pathways (Hientz et al., 2017). This evidence concerns the gene TP53 and neoplasm.